{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:13:19Z","timestamp":1790615599957,"version":"4.1.0"},"reference-count":114,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007560","name":"Chiesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Perinatology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.clp.2019.02.013","type":"journal-article","created":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T08:29:22Z","timestamp":1553934562000},"page":"349-366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Analgesia, Opioids, and Other Drug Use During Pregnancy and Neonatal Abstinence Syndrome"],"prefix":"10.1016","volume":"46","author":[{"given":"Hendr\u00e9e E.","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter K.","family":"Kraft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clp.2019.02.013_bib1","series-title":"American security today. DEA: fentanyl-related overdose deaths rising at an alarming rate","author":"Waite","year":"2016"},{"key":"10.1016\/j.clp.2019.02.013_bib2","series-title":"Drug overdose death data","author":"Centers for disease control and prevention (CDC)","year":"2017"},{"key":"10.1016\/j.clp.2019.02.013_bib3","series-title":"Results from the 2016 national survey on drug use and health: detailed tables","author":"Center for behavioral health statistics and quality","year":"2017"},{"issue":"5","key":"10.1016\/j.clp.2019.02.013_bib4","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3109\/10826089609045825","article-title":"The differences between male and female drug users: community samples of heroin and cocaine users compared","volume":"31","author":"Powis","year":"1996","journal-title":"Subst Use Misuse"},{"issue":"2\u20133","key":"10.1016\/j.clp.2019.02.013_bib5","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.drugalcdep.2009.10.007","article-title":"Needle sharing in regular sexual relationships: an examination of serodiscordance, drug using practices, and the gendered character of injecting","volume":"107","author":"Bryant","year":"2010","journal-title":"Drug Alcohol Depend"},{"issue":"11","key":"10.1016\/j.clp.2019.02.013_bib6","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1080\/10826080500222834","article-title":"Injection risk behavior among women syringe exchangers in San Francisco","volume":"40","author":"Lum","year":"2005","journal-title":"Subst Use Misuse"},{"issue":"5","key":"10.1016\/j.clp.2019.02.013_bib7","first-page":"379","article-title":"A\u00a0comparison of HIV risk between women and men who inject drugs","volume":"6","author":"Dwyer","year":"1994","journal-title":"AIDS Educ Prev"},{"issue":"1","key":"10.1016\/j.clp.2019.02.013_bib8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jsat.2012.12.007","article-title":"Gender differences in a clinical trial for prescription opioid dependence","volume":"45","author":"McHugh","year":"2013","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"31","key":"10.1016\/j.clp.2019.02.013_bib9","doi-asserted-by":"crossref","first-page":"845","DOI":"10.15585\/mmwr.mm6731a1","article-title":"Opioid use disorder documented at delivery hospitalization - United States, 1999-2014","volume":"67","author":"Haight","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.clp.2019.02.013_bib10","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-3520","article-title":"Incidence and costs of neonatal abstinence syndrome among infants with Medicaid: 2004-2014","volume":"141","author":"Winkelman","year":"2018","journal-title":"Pediatrics"},{"issue":"18","key":"10.1016\/j.clp.2019.02.013_bib11","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.2012.3951","article-title":"Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009","volume":"307","author":"Patrick","year":"2012","journal-title":"JAMA"},{"issue":"31","key":"10.1016\/j.clp.2019.02.013_bib12","doi-asserted-by":"crossref","first-page":"799","DOI":"10.15585\/mmwr.mm6531a2","article-title":"Incidence of neonatal abstinence syndrome - 28 states, 1999-2013","volume":"65","author":"Ko","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.clp.2019.02.013_bib13","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00006250-200608000-00046","article-title":"ACOG committee opinion no. 343: psychosocial risk factors: perinatal screening and intervention","volume":"108","author":"American College of Obstetricians and Gynecologists","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.clp.2019.02.013_bib14","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/AOG.0000000000001781","article-title":"Neonatal abstinence syndrome and ethical approaches to the identification of pregnant women who use drugs","volume":"129","author":"Terplan","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.clp.2019.02.013_bib15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.31887\/DCNS.2017.19.3\/wberrettini","article-title":"A\u00a0brief review of the genetics and pharmacogenetics of opioid use disorders","volume":"19","author":"Berrettini","year":"2017","journal-title":"Dialogues Clin Neurosci"},{"issue":"7","key":"10.1016\/j.clp.2019.02.013_bib16","doi-asserted-by":"crossref","first-page":"991","DOI":"10.2105\/AJPH.86.7.991","article-title":"Violence and substance use among North Carolina pregnant women","volume":"86","author":"Martin","year":"1996","journal-title":"Am J Public Health"},{"issue":"8","key":"10.1016\/j.clp.2019.02.013_bib17","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1176\/ps.62.8.pss6208_0959","article-title":"Mental health of victims of intimate partner violence: results from a national epidemiologic survey","volume":"62","author":"Okuda","year":"2011","journal-title":"Psychiatr Serv"},{"issue":"3","key":"10.1016\/j.clp.2019.02.013_bib18","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/AOG.0000000000002493","article-title":"The comprehensive addiction and recovery act: opioid use disorder and midwifery practice","volume":"131","author":"Murphy","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clp.2019.02.013_bib19","unstructured":"Center for Substance Abuse Treatment. 1993. Available at: http:\/\/adaiclearinghouse.org\/downloads\/TIP-2-Pregnant-Substance-Using-Women-83.pdf. Accessed March 18, 2019."},{"issue":"2","key":"10.1016\/j.clp.2019.02.013_bib20","first-page":"90","article-title":"Medically assisted withdrawal (detoxification): considering the mother-infant dyad","volume":"11","author":"Jones","year":"2017","journal-title":"J\u00a0Addict Med"},{"issue":"5","key":"10.1016\/j.clp.2019.02.013_bib21","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/AOG.0000000000002562","article-title":"Opioid detoxification during pregnancy: a systematic review","volume":"131","author":"Terplan","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.clp.2019.02.013_bib22","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/AOG.0b013e318256496e","article-title":"ACOG committee opinion no. 524: opioid abuse, dependence, and addiction in pregnancy","volume":"119","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.clp.2019.02.013_bib23","first-page":"358","article-title":"American Society of Addiction Medicine (ASAM) national practice guideline for the use of medications in the treatment of addiction involving opioid use","volume":"9","author":"Kampman","year":"2015","journal-title":"J\u00a0Addict Med"},{"key":"10.1016\/j.clp.2019.02.013_bib24","series-title":"International standards for the treatment of drug use disorders","year":"2016"},{"key":"10.1016\/j.clp.2019.02.013_bib25","series-title":"Guidelines for the identification and management of substance use and substance use disorders in pregnancy","year":"2014"},{"key":"10.1016\/j.clp.2019.02.013_bib26","series-title":"Federal guidelines for opioid treatment programs. HS publication no. (SMA)PEP 15-FEDGUIDEOTP","year":"2015"},{"issue":"1","key":"10.1016\/j.clp.2019.02.013_bib27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0889-8545(05)70362-4","article-title":"Opioid dependence during pregnancy. Effects and management","volume":"25","author":"Kaltenbach","year":"1998","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.clp.2019.02.013_bib28","series-title":"Medication-assisted treatment for opioid addiction in opioid treatment programs inservice training. HHS publication no. (SMA) 09-4341","author":"Center for substance abuse treatment","year":"2008"},{"key":"10.1016\/j.clp.2019.02.013_bib29","series-title":"Methadone treatment for opioid dependence","first-page":"455","article-title":"Specialty treatment for women","author":"Jones","year":"2006"},{"issue":"2","key":"10.1016\/j.clp.2019.02.013_bib30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0378-3782(77)90017-2","article-title":"The narcotic-dependent mother: fetal and neonatal consequences","volume":"1","author":"Kandall","year":"1977","journal-title":"Early Hum Dev"},{"issue":"Suppl 1","key":"10.1016\/j.clp.2019.02.013_bib31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1360-0443.2012.04035.x","article-title":"Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review","volume":"107","author":"Jones","year":"2012","journal-title":"Addiction"},{"issue":"24","key":"10.1016\/j.clp.2019.02.013_bib32","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone or buprenorphine exposure","volume":"363","author":"Jones","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.clp.2019.02.013_bib33","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1111\/add.13462","article-title":"Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child","volume":"111","author":"Zedler","year":"2016","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.clp.2019.02.013_bib34","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1521-0391.2012.12005.x","article-title":"Buprenorphine\u00a0+ naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data","volume":"22","author":"Debelak","year":"2013","journal-title":"Am J Addict"},{"key":"10.1016\/j.clp.2019.02.013_bib35","first-page":"61","article-title":"A\u00a0comparison of buprenorphine\u00a0+ naloxone to buprenorphine and methadone in the treatment of opioid dependence during pregnancy: maternal and neonatal outcomes","volume":"7","author":"Lund","year":"2013","journal-title":"Subst Abuse"},{"issue":"10","key":"10.1016\/j.clp.2019.02.013_bib36","doi-asserted-by":"crossref","first-page":"e011774","DOI":"10.1136\/bmjopen-2016-011774","article-title":"Observational study of the safety of buprenorphine+naloxone in pregnancy in a rural and remote population","volume":"6","author":"Jumah","year":"2016","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.clp.2019.02.013_bib37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jsat.2014.07.007","article-title":"Recent trends in treatment admissions for prescription opioid abuse during pregnancy","volume":"48","author":"Martin","year":"2015","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"4","key":"10.1016\/j.clp.2019.02.013_bib38","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1080\/08897077.2016.1146649","article-title":"Factors associated with buprenorphine versus methadone use in pregnancy","volume":"37","author":"Krans","year":"2016","journal-title":"Subst Abus"},{"issue":"2 Pt 1","key":"10.1016\/j.clp.2019.02.013_bib39","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/01.AOG.0000275288.47258.e0","article-title":"Intrapartum and postpartum analgesia for women maintained on methadone during pregnancy","volume":"110","author":"Meyer","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"4 Suppl","key":"10.1016\/j.clp.2019.02.013_bib40","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1097\/00002508-200207001-00007","article-title":"Abuse liability in opioid therapy for pain treatment in patients with an addiction history","volume":"18","author":"Weaver","year":"2002","journal-title":"Clin J Pain"},{"issue":"3","key":"10.1016\/j.clp.2019.02.013_bib41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/00952990902825413","article-title":"Management of acute postpartum pain in patients maintained on methadone or buprenorphine during pregnancy","volume":"35","author":"Jones","year":"2009","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"2","key":"10.1016\/j.clp.2019.02.013_bib42","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0022-3565(25)39357-2","article-title":"Precipitated withdrawal by pentazocine in methadone-maintained volunteers","volume":"267","author":"Strain","year":"1993","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.clp.2019.02.013_bib43","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/089033440001600206","article-title":"Methadone levels in human milk","volume":"16","author":"McCarthy","year":"2000","journal-title":"J\u00a0Hum Lact"},{"issue":"3","key":"10.1016\/j.clp.2019.02.013_bib44","doi-asserted-by":"crossref","first-page":"e827","DOI":"10.1542\/peds.2011-3552","article-title":"Breastfeeding and the use of human milk","volume":"129","year":"2012","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.clp.2019.02.013_bib45","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/0890334403261027","article-title":"Methadone maintenance and lactation: a review of the literature and current management guidelines","volume":"20","author":"Jansson","year":"2004","journal-title":"J\u00a0Hum Lact"},{"issue":"6","key":"10.1016\/j.clp.2019.02.013_bib46","doi-asserted-by":"crossref","first-page":"e1163","DOI":"10.1542\/peds.2005-1561","article-title":"Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers","volume":"117","author":"Abdel-Latif","year":"2006","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.clp.2019.02.013_bib47","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0009-9236(97)90053-9","article-title":"Buprenorphine withdrawal syndrome in a newborn","volume":"62","author":"Marquet","year":"1997","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.clp.2019.02.013_bib48","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.forsciint.2005.04.013","article-title":"Assessment of exposure to opiates and cocaine during pregnancy in a Mediterranean city: preliminary results of the \"meconium project.\"","volume":"153","author":"Pichini","year":"2005","journal-title":"Forensic Sci Int"},{"issue":"1","key":"10.1016\/j.clp.2019.02.013_bib49","first-page":"19","article-title":"Cocaine use and the breastfeeding mother","volume":"18","author":"Jones","year":"2015","journal-title":"Pract Midwife"},{"issue":"1","key":"10.1016\/j.clp.2019.02.013_bib50","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/01.AOG.0000467192.89321.a6","article-title":"Committee opinion no. 637: marijuana use during pregnancy and lactation","volume":"126","author":"American College of Obstetricians and Gynecologists Committee on Obstetric Practice","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clp.2019.02.013_bib51","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.drugalcdep.2015.02.012","article-title":"Medication assisted treatment discontinuation in pregnant and postpartum women with opioid use disorder","volume":"149","author":"Wilder","year":"2015","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.clp.2019.02.013_bib52","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1097\/AOG.0000000000002235","article-title":"Committee opinion no. 711: opioid use and opioid use disorder in pregnancy","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.clp.2019.02.013_bib53","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/AOG.0000000000001695","article-title":"Maternal deaths from suicide and overdose in Colorado, 2004-2012","volume":"128","author":"Metz","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clp.2019.02.013_bib54","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jsat.2017.12.001","article-title":"Predictors of treatment retention in postpartum women prescribed buprenorphine during pregnancy","volume":"86","author":"O'Connor","year":"2018","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"6","key":"10.1016\/j.clp.2019.02.013_bib55","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1056\/NEJMc1715957","article-title":"Maternal health in the United States","volume":"378","author":"Schiff","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.clp.2019.02.013_bib56","doi-asserted-by":"crossref","first-page":"e1208","DOI":"10.1542\/peds.2009-0489","article-title":"Tolerance and withdrawal from prolonged opioid use in critically ill children","volume":"125","author":"Anand","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.clp.2019.02.013_bib57","series-title":"Neonatal Opioid withdrawal syndrome and medication-assisted treatment with methadone and buprenorphine","author":"FDA","year":"2016"},{"issue":"6 Pt 1","key":"10.1016\/j.clp.2019.02.013_bib58","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1542\/peds.111.6.1318","article-title":"Smoking during pregnancy and newborn neurobehavior","volume":"111","author":"Law","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.clp.2019.02.013_bib59","series-title":"FDA drug safety communication: antipsychotic drug labels updated on use during pregnancy and risk of abnormal muscle movements and withdrawal symptoms in newborns","author":"Food and Drug Administration","year":"2011"},{"issue":"11","key":"10.1016\/j.clp.2019.02.013_bib60","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1503\/cmaj.1041100","article-title":"Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates?","volume":"172","author":"Koren","year":"2005","journal-title":"CMAJ"},{"key":"10.1016\/j.clp.2019.02.013_bib61","doi-asserted-by":"crossref","first-page":"j3326","DOI":"10.1136\/bmj.j3326","article-title":"Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study","volume":"358","author":"Huybrechts","year":"2017","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.clp.2019.02.013_bib62","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.drugalcdep.2012.11.019","article-title":"Cigarette smoking in opioid-dependent pregnant women: neonatal and maternal outcomes","volume":"131","author":"Jones","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.clp.2019.02.013_bib63","doi-asserted-by":"crossref","first-page":"h2102","DOI":"10.1136\/bmj.h2102","article-title":"Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study","volume":"350","author":"Desai","year":"2015","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.clp.2019.02.013_bib64","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1111\/j.1360-0443.2010.03120.x","article-title":"Methadone dose and neonatal abstinence syndrome-systematic review and meta-analysis","volume":"105","author":"Cleary","year":"2010","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.clp.2019.02.013_bib65","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00004703-199804000-00005","article-title":"The neonatal withdrawal inventory: a simplified score of newborn withdrawal","volume":"19","author":"Zahorodny","year":"1998","journal-title":"J\u00a0Dev Behav Pediatr"},{"issue":"6","key":"10.1016\/j.clp.2019.02.013_bib66","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1177\/000992287501400613","article-title":"A\u00a0proposed narcotic withdrawal score for use with newborn infants. A pragmatic evaluation of its efficacy","volume":"14","author":"Lipsitz","year":"1975","journal-title":"Clin Pediatr (phila)"},{"key":"10.1016\/j.clp.2019.02.013_bib67","series-title":"Current pediatric therapy","first-page":"800","article-title":"Infants of drug-dependent mothers","author":"Ostrea","year":"1993"},{"issue":"2","key":"10.1016\/j.clp.2019.02.013_bib68","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/00952998108999125","article-title":"The neonatal narcotic withdrawal index: a device for the improvement of care in the abstinence syndrome","volume":"8","author":"Green","year":"1981","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"1\u20132","key":"10.1016\/j.clp.2019.02.013_bib69","first-page":"141","article-title":"Neonatal abstinence syndrome: assessment and management","volume":"2","author":"Finnegan","year":"1975","journal-title":"Addict Dis"},{"issue":"3","key":"10.1016\/j.clp.2019.02.013_bib70","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1360-0443.2009.02802.x","article-title":"Finnegan neonatal abstinence scoring system: normal values for first 3\u00a0days and weeks 5-6 in non-addicted infants","volume":"105","author":"Zimmermann-Baer","year":"2010","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.clp.2019.02.013_bib71","doi-asserted-by":"crossref","first-page":"409","DOI":"10.5055\/jom.2010.0038","article-title":"Neonatal abstinence scores in opioid-exposed and nonexposed neonates: a blinded comparison","volume":"6","author":"Jones","year":"2010","journal-title":"J\u00a0Opioid Manag"},{"issue":"1","key":"10.1016\/j.clp.2019.02.013_bib72","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5055\/jom.2016.0308","article-title":"Measurement of neonatal abstinence syndrome: evaluation of short forms","volume":"12","author":"Jones","year":"2016","journal-title":"J\u00a0Opioid Manag"},{"issue":"7","key":"10.1016\/j.clp.2019.02.013_bib73","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/phar.1948","article-title":"Early prediction tool to identify the need for pharmacotherapy in infants at risk of neonatal abstinence syndrome","volume":"37","author":"Isemann","year":"2017","journal-title":"Pharmacotherapy"},{"issue":"6","key":"10.1016\/j.clp.2019.02.013_bib74","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/ANC.0000000000000033","article-title":"Validation of the Finnegan neonatal abstinence syndrome tool-short form","volume":"13","author":"Maguire","year":"2013","journal-title":"Adv Neonatal Care"},{"issue":"9","key":"10.1016\/j.clp.2019.02.013_bib75","doi-asserted-by":"crossref","first-page":"e016176","DOI":"10.1136\/bmjopen-2017-016176","article-title":"Simplification of the Finnegan neonatal abstinence scoring system: retrospective study of two institutions in the USA","volume":"7","author":"Gomez Pomar","year":"2017","journal-title":"BMJ Open"},{"issue":"8","key":"10.1016\/j.clp.2019.02.013_bib76","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/s41372-018-0109-8","article-title":"Quality improvement initiative to improve inpatient outcomes for neonatal abstinence syndrome","volume":"38","author":"Wachman","year":"2018","journal-title":"J\u00a0Perinatol"},{"issue":"6","key":"10.1016\/j.clp.2019.02.013_bib77","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-3360","article-title":"An initiative to improve the quality of care of infants with neonatal abstinence syndrome","volume":"139","author":"Grossman","year":"2017","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.clp.2019.02.013_bib78","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-2929","article-title":"Rooming-in to treat neonatal abstinence syndrome: improved family-centered care at lower cost","volume":"137","author":"Holmes","year":"2016","journal-title":"Pediatrics"},{"issue":"10","key":"10.1016\/j.clp.2019.02.013_bib79","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1080\/14767058.2017.1414180","article-title":"Nonpharmacological management of\u00a0neonatal abstinence syndrome: a review of the literature","volume":"32","author":"Ryan","year":"2019","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"issue":"3","key":"10.1016\/j.clp.2019.02.013_bib80","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1177\/0890334416641909","article-title":"Breastfeeding among mothers on opioid maintenance treatment: a literature review","volume":"32","author":"Tsai","year":"2016","journal-title":"J\u00a0Hum Lact"},{"key":"10.1016\/j.clp.2019.02.013_bib81","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1089\/bfm.2016.0084","article-title":"The association between breastfeeding and length of hospital stay among infants diagnosed with neonatal abstinence syndrome: a population-based study of in-hospital births","volume":"11","author":"Short","year":"2016","journal-title":"Breastfeed Med"},{"issue":"12","key":"10.1016\/j.clp.2019.02.013_bib82","first-page":"e555","article-title":"Rooming-in care for infants of opioid-dependent mothers: implementation and evaluation at a tertiary care hospital","volume":"61","author":"Newman","year":"2015","journal-title":"Can Fam Physician"},{"issue":"10","key":"10.1016\/j.clp.2019.02.013_bib83","first-page":"1722","article-title":"Rooming-in compared with standard care for newborns of mothers using methadone or heroin","volume":"53","author":"Abrahams","year":"2007","journal-title":"Can Fam Physician"},{"issue":"5","key":"10.1016\/j.clp.2019.02.013_bib84","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1055\/s-0035-1566295","article-title":"Rooming-in for infants at risk of neonatal abstinence syndrome","volume":"33","author":"McKnight","year":"2016","journal-title":"Am J Perinatol"},{"issue":"2","key":"10.1016\/j.clp.2019.02.013_bib85","article-title":"Buprenorphine for managing opioid withdrawal","author":"Gowing","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.clp.2019.02.013_bib86","article-title":"Alpha(2)-adrenergic agonists for the management of opioid withdrawal","author":"Gowing","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clp.2019.02.013_bib87","first-page":"1","article-title":"The effect of standardizing treatment when managing neonatal abstinence syndrome","author":"Burnette","year":"2018","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"issue":"2","key":"10.1016\/j.clp.2019.02.013_bib88","doi-asserted-by":"crossref","first-page":"e527","DOI":"10.1542\/peds.2013-4036","article-title":"A\u00a0multicenter cohort study of treatments and hospital outcomes in neonatal abstinence syndrome","volume":"134","author":"Hall","year":"2014","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.clp.2019.02.013_bib89","doi-asserted-by":"crossref","first-page":"e803","DOI":"10.1542\/peds.2015-1141","article-title":"Implementation of a neonatal abstinence syndrome weaning protocol: a multicenter cohort study","volume":"136","author":"Hall","year":"2015","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.clp.2019.02.013_bib90","doi-asserted-by":"crossref","first-page":"e1494","DOI":"10.1542\/peds.2014-1269","article-title":"A\u00a0quality improvement project to reduce length of stay for neonatal abstinence syndrome","volume":"135","author":"Asti","year":"2015","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.clp.2019.02.013_bib91","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3835","article-title":"Improving care for neonatal abstinence syndrome","volume":"137","author":"Patrick","year":"2016","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.clp.2019.02.013_bib92","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/jamapediatrics.2018.1307","article-title":"Comparison of safety and efficacy of methadone vs morphine for treatment of neonatal abstinence syndrome: a randomized clinical trial","volume":"172","author":"Davis","year":"2018","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.clp.2019.02.013_bib93","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jpeds.2018.07.061","article-title":"Morphine vs methadone treatment for infants with neonatal abstinence syndrome","volume":"203","author":"Tolia","year":"2018","journal-title":"J\u00a0Pediatr"},{"issue":"24","key":"10.1016\/j.clp.2019.02.013_bib94","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1056\/NEJMoa1614835","article-title":"Buprenorphine for the treatment of the neonatal abstinence syndrome","volume":"376","author":"Kraft","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clp.2019.02.013_bib95","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jpeds.2015.11.039","article-title":"A\u00a0cohort comparison of buprenorphine versus methadone treatment for neonatal abstinence syndrome","volume":"170","author":"Hall","year":"2016","journal-title":"J\u00a0Pediatr"},{"issue":"4","key":"10.1016\/j.clp.2019.02.013_bib96","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1055\/s-0037-1608634","article-title":"Comparison of neonatal abstinence syndrome treatment with sublingual buprenorphine versus conventional opioids","volume":"35","author":"Hall","year":"2018","journal-title":"Am J Perinatol"},{"issue":"10","key":"10.1016\/j.clp.2019.02.013_bib97","first-page":"997","article-title":"Buprenorphine for the neonatal abstinence syndrome","volume":"377","author":"Kraft","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.clp.2019.02.013_bib98","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/jcph.696","article-title":"Mechanistic population pharmacokinetics of morphine in neonates with abstinence syndrome after oral administration of diluted tincture of opium","volume":"56","author":"Liu","year":"2016","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"9","key":"10.1016\/j.clp.2019.02.013_bib99","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/psp4.12112","article-title":"A\u00a0population pharmacokinetic model for vancomycin in adult patients receiving extracorporeal membrane oxygenation therapy","volume":"5","author":"Moore","year":"2016","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"6","key":"10.1016\/j.clp.2019.02.013_bib100","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jpeds.2015.08.032","article-title":"Pharmacokinetics of oral methadone in the treatment of neonatal abstinence syndrome: a pilot study","volume":"167","author":"Wiles","year":"2015","journal-title":"J\u00a0Pediatr"},{"issue":"4","key":"10.1016\/j.clp.2019.02.013_bib101","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1177\/0091270010370587","article-title":"Clonidine clearance matures rapidly during the early postnatal period: a population pharmacokinetic analysis in newborns with neonatal abstinence syndrome","volume":"51","author":"Xie","year":"2011","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.clp.2019.02.013_bib102","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.jpeds.2015.09.038","article-title":"Cohort analysis of a pharmacokinetic-modeled methadone weaning optimization for neonatal abstinence syndrome","volume":"167","author":"Hall","year":"2015","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clp.2019.02.013_bib103","first-page":"1","article-title":"Outpatient pharmacologic weaning for neonatal abstinence syndrome: a systematic review","author":"Murphy-Oikonen","year":"2018","journal-title":"Prim Health Care Res Dev"},{"key":"10.1016\/j.clp.2019.02.013_bib104","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jpeds.2018.03.048","article-title":"Outpatient pharmacotherapy for neonatal abstinence syndrome","volume":"199","author":"Maalouf","year":"2018","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clp.2019.02.013_bib105","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3389\/fped.2017.00242","article-title":"Neonatal abstinence syndrome: twins case series","volume":"5","author":"Pandey","year":"2017","journal-title":"Front Pediatr"},{"key":"10.1016\/j.clp.2019.02.013_bib106","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.copsyc.2018.07.014","article-title":"A\u00a0review of opioid addiction genetics","volume":"27","author":"Crist","year":"2018","journal-title":"Curr Opin Psychol"},{"issue":"17","key":"10.1016\/j.clp.2019.02.013_bib107","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1001\/jama.2013.3411","article-title":"Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome","volume":"309","author":"Wachman","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.clp.2019.02.013_bib108","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.drugalcdep.2015.07.001","article-title":"Variations in opioid receptor genes in neonatal abstinence syndrome","volume":"155","author":"Wachman","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.clp.2019.02.013_bib109","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1016\/j.drugalcdep.2014.09.219","article-title":"Neonatal abstinence syndrome in methadone exposed infants: role of genetic variability","volume":"146","author":"Fielder","year":"2015","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"10.1016\/j.clp.2019.02.013_bib110","doi-asserted-by":"crossref","first-page":"e12476","DOI":"10.1111\/gbb.12476","article-title":"Epigenetic variation in OPRM1 gene in opioid-exposed mother-infant dyads","volume":"17","author":"Wachman","year":"2018","journal-title":"Genes Brain Behav"},{"issue":"3","key":"10.1016\/j.clp.2019.02.013_bib111","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jpeds.2014.05.040","article-title":"Epigenetic variation in the mu-opioid receptor gene in infants with neonatal abstinence syndrome","volume":"165","author":"Wachman","year":"2014","journal-title":"J\u00a0Pediatr"},{"issue":"5","key":"10.1016\/j.clp.2019.02.013_bib112","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.adnc.2005.06.003","article-title":"A\u00a0retrospective study of length of hospital stay in infants treated for neonatal abstinence syndrome with methadone versus oral morphine preparations","volume":"5","author":"Lainwala","year":"2005","journal-title":"Adv Neonatal Care"},{"issue":"23 Suppl 3","key":"10.1016\/j.clp.2019.02.013_bib113","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.2146\/sp150025","article-title":"Retrospective chart review comparing morphine and methadone in neonates treated for neonatal abstinence syndrome","volume":"72","author":"Young","year":"2015","journal-title":"Am J Health Syst Pharm"},{"issue":"4","key":"10.1016\/j.clp.2019.02.013_bib114","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/jp.2014.194","article-title":"Methadone versus morphine for treatment of neonatal abstinence syndrome: a prospective randomized clinical trial","volume":"35","author":"Brown","year":"2015","journal-title":"J\u00a0Perinatol"}],"container-title":["Clinics in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510819300247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510819300247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:58:51Z","timestamp":1758815931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095510819300247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":114,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0095510819300247"],"URL":"https:\/\/doi.org\/10.1016\/j.clp.2019.02.013","relation":{},"ISSN":["0095-5108"],"issn-type":[{"value":"0095-5108","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analgesia, Opioids, and Other Drug Use During Pregnancy and Neonatal Abstinence Syndrome","name":"articletitle","label":"Article Title"},{"value":"Clinics in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clp.2019.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}